Phase II study of oral trofosfamide as palliative therapy in pretreated patients with metastatic soft-tissue sarcoma

Anti-Cancer Drugs ◽

10.1097/00001813-199906000-00004 ◽

1999 ◽

Vol 10 (5) ◽

pp. 453-456 ◽

Author(s):

Christian Kollmannsberger ◽

Wolfram Brugger ◽

Jörg T Hartmann ◽

Franz Maurer ◽

Paul Böhm ◽

...

Keyword(s):

Soft Tissue ◽

Soft Tissue Sarcoma ◽

Phase Ii ◽

Phase Ii Study ◽

Palliative Therapy ◽

Metastatic Soft Tissue Sarcoma ◽

Pretreated Patients

Download Full-text

Updated results of Phase II study of trabectedin (ET-743) in pretreated patients with advanced/metastatic soft tissue sarcoma from a single institute

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.21506 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 21506-21506 ◽

Author(s):

V. Mohan ◽

T. Chawla ◽

K. Alzwahereh ◽

W. Jeong ◽

K. Y. Kita ◽

...

Keyword(s):

Soft Tissue ◽

Soft Tissue Sarcoma ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Soft Tissue Sarcoma ◽

Pretreated Patients

Download Full-text

Combination of Nivolumab Plus Relatlimab in Patients With Advanced or Metastatic Soft-tissue Sarcoma: a Proof-of-concept Randomized Phase II Study

Case Medical Research ◽

10.31525/ct1-nct04095208 ◽

2019 ◽

Author(s):

Keyword(s):

Soft Tissue ◽

Soft Tissue Sarcoma ◽

Phase Ii ◽

Phase Ii Study ◽

Proof Of Concept ◽

Randomized Phase Ii ◽

Metastatic Soft Tissue Sarcoma

Download Full-text

1652P A prospective, single-arm phase II study of pegylated-liposome doxorubincin combined with ifosfamide as first-line treatment for patients with advanced or metastatic soft tissue sarcoma

Annals of Oncology ◽

10.1016/j.annonc.2020.08.1878 ◽

2020 ◽

Vol 31 ◽

pp. S986

Author(s):

X. Liu ◽

X. Zhang ◽

J. Cao ◽

H. Wang ◽

X. Wu ◽

...

Keyword(s):

Soft Tissue ◽

Soft Tissue Sarcoma ◽

Phase Ii ◽

Phase Ii Study ◽

Line Treatment ◽

Pegylated Liposome ◽

Metastatic Soft Tissue Sarcoma ◽

First Line Treatment

Download Full-text

Brostallicin versus doxorubicin as first-line chemotherapy in patients with advanced or metastatic soft tissue sarcoma: An EORTC Soft Tissue and Bone Sarcoma Group randomized phase II study.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.10037 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 10037-10037 ◽

Author(s):

H. Gelderblom ◽

J. Blay ◽

B. M. Seddon ◽

M. Leahy ◽

I. L. Ray-Coquard ◽

...

Keyword(s):

Soft Tissue ◽

Soft Tissue Sarcoma ◽

Phase Ii ◽

Phase Ii Study ◽

Bone Sarcoma ◽

Randomized Phase Ii ◽

Metastatic Soft Tissue Sarcoma ◽

Line Chemotherapy

Download Full-text

9404 A Phase II study of cediranib in patients with metastatic gastrointestinal stromal tumours (GIST) and metastatic soft tissue sarcoma (STS) (including alveolar soft part sarcoma [ASPS])

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(09)71992-5 ◽

2009 ◽

Vol 7 (2) ◽

pp. 591 ◽

Author(s):

K. Gardner ◽

I. Judson ◽

M. Leahy ◽

E. Barquin ◽

M. Marotti ◽

...

Keyword(s):

Soft Tissue ◽

Soft Tissue Sarcoma ◽

Phase Ii ◽

Phase Ii Study ◽

Soft Part ◽

Alveolar Soft Part Sarcoma ◽

Gastrointestinal Stromal Tumours ◽

Metastatic Soft Tissue Sarcoma

Download Full-text

Phase II study of gemcitabine/vinorelbine (GV) as first or second line chemotherapy in patients with metastatic soft tissue sarcoma (STS)

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.9009 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 9009-9009 ◽

Author(s):

J. A. Morgan ◽

S. George ◽

J. Desai ◽

M. St. Amand ◽

D. Horton ◽

...

Keyword(s):

Soft Tissue ◽

Soft Tissue Sarcoma ◽

Phase Ii ◽

Phase Ii Study ◽

Second Line ◽

Second Line Chemotherapy ◽

Metastatic Soft Tissue Sarcoma ◽

Line Chemotherapy

Download Full-text

Randomized comparison of pazopanib (PAZ) and doxorubicin (DOX) in the first line treatment of metastatic soft tissue sarcoma (STS) in elderly patients (pts): Results of a phase II study (EPAZ).

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.11506 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. 11506-11506 ◽

Author(s):

Viktor Grünwald ◽

Annegret Kunitz ◽

Markus Kajo Schuler ◽

Patrick Schoffski ◽

Hans-Georg Kopp ◽

...

Keyword(s):

Soft Tissue ◽

Soft Tissue Sarcoma ◽

Elderly Patients ◽

Phase Ii ◽

Phase Ii Study ◽

Line Treatment ◽

Metastatic Soft Tissue Sarcoma ◽

First Line Treatment

Download Full-text

Brostallicin, an agent with potential activity in metastatic soft tissue sarcoma: A phase II study from the European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group

European Journal of Cancer ◽

10.1016/j.ejca.2006.09.014 ◽

2007 ◽

Vol 43 (2) ◽

pp. 308-315 ◽

Author(s):

Michael Leahy ◽

Isabelle Ray-Coquard ◽

Jaap Verweij ◽

Axel Le Cesne ◽

Florence Duffaud ◽

...

Keyword(s):

Soft Tissue ◽

Soft Tissue Sarcoma ◽

Phase Ii ◽

Phase Ii Study ◽

Bone Sarcoma ◽

European Organisation ◽

Metastatic Soft Tissue Sarcoma ◽

Potential Activity

Download Full-text

Phase II study of elliptinium in metastatic soft tissue sarcoma

European Journal of Cancer and Clinical Oncology ◽

10.1016/0277-5379(85)90086-0 ◽

1985 ◽

Vol 21 (5) ◽

pp. 591-593 ◽

Author(s):

R. Somers ◽

J. Rouësse ◽

A. van Oosterom ◽

D. Thomas

Keyword(s):

Soft Tissue ◽

Soft Tissue Sarcoma ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Soft Tissue Sarcoma

Download Full-text

Phase II study of nimustine in metastatic soft tissue sarcoma

European Journal of Cancer and Clinical Oncology ◽

10.1016/0277-5379(91)90424-c ◽

1991 ◽

Vol 27 (12) ◽

pp. 1604-1605 ◽

Author(s):

D.J.Th. Wagener ◽

R. Somers ◽

A. Santoro ◽

J. Verweij ◽

P.J. Woll ◽

...

Keyword(s):

Soft Tissue ◽

Soft Tissue Sarcoma ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Soft Tissue Sarcoma

Download Full-text